84.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$86.28
Aprire:
$86.41
Volume 24 ore:
67,142
Relative Volume:
0.76
Capitalizzazione di mercato:
$1.08B
Reddito:
$86.28M
Utile/perdita netta:
$23.61M
Rapporto P/E:
45.93
EPS:
1.8359
Flusso di cassa netto:
$23.97M
1 W Prestazione:
-0.71%
1M Prestazione:
-9.72%
6M Prestazione:
-0.38%
1 anno Prestazione:
+62.59%
Iradimed Corp Stock (IRMD) Company Profile
Nome
Iradimed Corp
Settore
Industria
Telefono
(407) 677-8022
Indirizzo
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
IRMD
Iradimed Corp
|
84.32 | 1.10B | 86.28M | 23.61M | 23.97M | 1.8359 |
|
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-04-12 | Iniziato | Lake Street | Buy |
| 2017-10-31 | Ripresa | ROTH Capital | Buy |
| 2016-10-05 | Downgrade | ROTH Capital | Buy → Neutral |
| 2015-11-02 | Reiterato | ROTH Capital | Buy |
| 2015-07-30 | Reiterato | ROTH Capital | Buy |
| 2015-06-16 | Reiterato | ROTH Capital | Buy |
| 2015-01-12 | Reiterato | ROTH Capital | Buy |
| 2014-12-23 | Reiterato | ROTH Capital | Buy |
Mostra tutto
Iradimed Corp Borsa (IRMD) Ultime notizie
Here's What We Like About IRADIMED's (NASDAQ:IRMD) Upcoming Dividend - Yahoo Finance
IRMD Stock Chart | IRADIMED CORP (NASDAQ:IRMD) - ChartMill
Iradimed CEO Roger Susi sells $642,861 in company stock By Investing.com - Investing.com South Africa
Iradimed CEO Roger Susi sells $642,861 in company stock - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under 10b5-1 plan - Stock Titan
IRadimed Corporation (NASDAQ:IRMD) Q1 2026 Earnings Call Transcript - Insider Monkey
A Look At IRADIMED (IRMD) Valuation After Q1 2026 Growth, New Pump Rollout And Dividend - Sahm
IRadimed Rides 3870 Momentum Despite Near-Term Dip - TipRanks
Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD? - Sahm
iRadimed (NASDAQ:IRMD) Issues Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
IRadimed Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Rating of "Buy" by Analysts - MarketBeat
IRADIMED (IRMD) Revenue Growth Track Tests Bullish MRI Demand Narratives - Sahm
iRadimed Corp (IRMD) Q1 2026 Earnings Call Highlights: Strong Re - GuruFocus
Why Iradimed Stock Topped the Market Today - Yahoo Finance
iRadimed Corp (IRMD) Shares Surge 4.4% -- What GF Score of 95 Te - GuruFocus
iRadimed Corporation (NASDAQ:IRMD) Plans Quarterly Dividend of $0.20 - MarketBeat
IRADIMED CORPORATION Files Form 8-K with SEC for May 2026 – Company Information, Address, and Stock Exchange Details - Minichart
IRADIMED CORP 1Q 2026: Revenue $21.98M, EPS $0.45— 10-Q Summary - TradingView
IRADIMED (NASDAQ: IRMD) Q1 2026 revenue rises 13% to $22M - Stock Titan
iRadimed (NASDAQ:IRMD) Sees Large Volume IncreaseShould You Buy? - MarketBeat
iRadimed Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Iradimed Co beats Q1 2026 expectations, stock dips - Investing.com
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
IRadimed Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Iradimed reports Q1 2026 revenue $22.0M, GAAP EPS $0.45; declares $0.20 quarterly dividend - TradingView
iRadimed (NASDAQ:IRMD) Updates FY 2026 Earnings Guidance - MarketBeat
iRadimed (NASDAQ:IRMD) Issues Q2 2026 Earnings Guidance - MarketBeat
IRADIMED ($IRMD) Releases Q1 2026 Earnings - Quiver Quantitative
IRADIMED (NASDAQ: IRMD) Q1 growth, dividend and 2026 outlook - Stock Titan
IRadimed: Q1 Earnings Snapshot - 10TV
MRI device maker IRADIMED launches new pump as Q1 sales climb 13% - Stock Titan
Roger Susi Sells 3,750 Shares of iRadimed (NASDAQ:IRMD) Stock - MarketBeat
Executive pay and director votes at Iradimed (NASDAQ: IRMD) 2026 meeting - Stock Titan
Iradimed CEO Susi’s trust sells $657,709 in company stock By Investing.com - Investing.com Australia
Iradimed CEO Susi’s trust sells $657,709 in company stock - Investing.com
How The Evolving Story For IRADIMED (IRMD) Is Shaping Analyst Targets And Fair Value - Yahoo Finance
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. - The Motley Fool
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors. - The Motley Fool
IRADIMED to post Q1 results before the bell May 1, call at 11 a.m. ET - Stock Titan
iRadimed (IRMD) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Iradimed Corp Stock Receives Strong Buy Ratings from Analysts - HarianBasis.co
Here is Why Investors Should Pay Attention to IRADIMED Corp. (IRMD) - Insider Monkey
iRadimed Corporation $IRMD Shares Sold by Copeland Capital Management LLC - MarketBeat
Iradimed earnings on deck: Can niche MRI device maker sustain growth? - Investing.com India
Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock - MarketBeat
Iradimed CEO Roger Susi sells $694k in common stock By Investing.com - Investing.com Australia
Iradimed CEO Roger Susi sells $694k in common stock - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under plan - Stock Titan
Tangible book value per share of IRadimed Corp. – LSX:A118V4 - TradingView
Insider Selling: iRadimed (NASDAQ:IRMD) CEO Sells 2,500 Shares of Stock - MarketBeat
Iradimed Corp Azioni (IRMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):